Voluntary Medical Male Circumcision: An HIV Prevention Priority for PEPFAR

Abstract: As the science demonstrating strong evidence for voluntary medical male circumcision (VMMC) for HIV prevention has evolved, the President's Emergency Plan for AIDS Relief (PEPFAR) has collaborated with international agencies, donors, and partner country governments supporting VMMC programming. Mathematical models forecast that quickly reaching a large number of uncircumcised men with VMMC in strategically chosen populations may dramatically reduce community-level HIV incidence and save billions of dollars in HIV care and treatment costs. Because VMMC is a 1-time procedure that confers life-long partial protection against HIV, programs for adult men are vital short-term investments with long-term benefits. VMMC also provides a unique opportunity to reach boys and men with HIV testing and counseling services and referrals for other HIV services, including treatment. After formal recommendations by WHO in 2007, priority countries have pursued expansion of VMMC. More than 1 million males have received VMMC thus far, with the most notable successes coming from Kenya's Nyanza Province. However, a myriad of necessary cultural, political, and ethical considerations have moderated the pace of overall success. Because many millions more uncircumcised men would benefit from VMMC services now, US President Barack Obama committed PEPFAR to provide 4.7 million males with VMMC by 2014. Innovative circumcision methods—such as medical devices that remove the foreskin without injected anesthesia and/or sutures—are being rigorously evaluated. Incorporation of safe innovations into surgical VMMC programs may provide the opportunity to reach more men more quickly with services and dramatically reduce HIV incidence for all.

[1]  C. Karema,et al.  One-Arm, Open-Label, Prospective, Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Scale-Up of Nonsurgical Circumcision When Performed by Nurses in Resource-Limited Settings for HIV Prevention , 2013, Journal of acquired immune deficiency syndromes.

[2]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[3]  C. Parker,et al.  Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection , 2012, AIDS.

[4]  S. Moses,et al.  The Effect of Medical Male Circumcision on Urogenital Mycoplasma genitalium Among Men in Kisumu, Kenya , 2012, Sexually transmitted diseases.

[5]  R. Gray,et al.  The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study , 2012, AIDS.

[6]  T. Quinn,et al.  Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. , 2012, The Journal of infectious diseases.

[7]  M. Hudgens,et al.  Multiple human papillomavirus infections and type competition in men. , 2012, The Journal of infectious diseases.

[8]  C. Parker,et al.  Circumcision Status and Incident HSV-2 Infection , Genital Ulcer Disease , and HIV Infection 1 , 2012 .

[9]  A. Binagwaho,et al.  Safety and Efficacy of the PrePex Device for Rapid Scale-Up of Male Circumcision for HIV Prevention in Resource-Limited Settings , 2011, Journal of acquired immune deficiency syndromes.

[10]  C. Hankins,et al.  Voluntary Medical Male Circumcision: Modeling the Impact and Cost of Expanding Male Circumcision for HIV Prevention in Eastern and Southern Africa , 2011, PLoS medicine.

[11]  S. Kent,et al.  Activation of NK Cells by ADCC Antibodies and HIV Disease Progression , 2011, Journal of acquired immune deficiency syndromes.

[12]  Philip S Li,et al.  The Shang Ring Device for Adult Male Circumcision: A Proof of Concept Study in Kenya , 2011, Journal of acquired immune deficiency syndromes.

[13]  T. Hope,et al.  The Role of the Foreskin in Male Circumcision: An Evidence‐Based Review , 2011, American journal of reproductive immunology.

[14]  N. Sewankambo,et al.  Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda , 2011, The Lancet.

[15]  Maliha Aziz,et al.  The Effects of Circumcision on the Penis Microbiome , 2010, PloS one.

[16]  O. Laeyendecker,et al.  Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. , 2009, The New England journal of medicine.

[17]  R. Gray,et al.  Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters) , 2009, AIDS.

[18]  M. Sherman,et al.  Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda , 2009, AIDS.

[19]  N. Nagelkerke,et al.  Male Circumcision for HIV Prevention in High HIV Prevalence Settings: What Can Mathematical Modelling Contribute to Informed Decision Making? , 2009, PLoS medicine.

[20]  E. Lagarde,et al.  Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. , 2009, The Journal of infectious diseases.

[21]  A. Puren,et al.  Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. , 2009, The Journal of infectious diseases.

[22]  S. Moses,et al.  Risk Compensation Is Not Associated with Male Circumcision in Kisumu, Kenya: A Multi-Faceted Assessment of Men Enrolled in a Randomized Controlled Trial , 2008, PloS one.

[23]  Swaziland Swaziland Demographic and Health Survey 2006-07 , 2008 .

[24]  J. Stockman Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial , 2008 .

[25]  J. Krieger,et al.  The protective effect of male circumcision is sustained for at least 42 months: results from the Kisumu, Kenya Trial , 2008 .

[26]  Zimbabwe Zimbabwe Demographic and Health Survey 2005-06 , 2007 .

[27]  Stephen Moses,et al.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial , 2007, The Lancet.

[28]  Oliver Laeyendecker,et al.  Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial , 2007, The Lancet.

[29]  R. Short,et al.  Potential HIV-1 target cells in the human penis , 2006, AIDS.

[30]  S. Moses,et al.  HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. , 2006, American journal of clinical pathology.

[31]  Emmanuel Lagarde,et al.  Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial , 2005, PLoS medicine.

[32]  R. Lucidi,et al.  Neonatal Circumcision: A Review of the World’s Oldest and Most Controversial Operation , 2004, Obstetrical & gynecological survey.

[33]  N. Michael,et al.  Joint United Nations Programme on HIV/AIDS. , 2004, Military medicine.

[34]  R. Bailey,et al.  Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. , 2002, The American journal of pathology.

[35]  Eto,et al.  THE NEW ENGLAND JOURNAL OF MEDICINE , 1977, The Lancet.

[36]  E. Lagarde,et al.  Male circumcision and HIV infection in four cities in sub-Saharan Africa , 2001, AIDS.

[37]  R. Hayes,et al.  Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis , 2000, AIDS.

[38]  R. Short,et al.  How does male circumcision protect against HIV infection? , 2000, BMJ : British Medical Journal.

[39]  T. Quinn,et al.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.

[40]  R. Bailey,et al.  Male circumcision and HIV infection: 10 years and counting , 1999, The Lancet.

[41]  Z. Samra,et al.  Comparative periurethral bacteriology of uncircumcised and circumcised males. , 1997, Genitourinary medicine.

[42]  N. Nagelkerke,et al.  Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. , 1990, International journal of epidemiology.

[43]  R. Brunham,et al.  FEMALE TO MALE TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1: RISK FACTORS FOR SEROCONVERSION IN MEN , 1989, The Lancet.

[44]  J. Bongaarts,et al.  The relationship between male circumcision and HIV infection in African populations. , 1989, AIDS.

[45]  Finkel Aj A possible explanation for heterosexual male infection with AIDS. , 1986 .

[46]  A. J. Fink A possible explanation for heterosexual male infection with AIDS. , 1986, The New England journal of medicine.

[47]  I. Nilsson,et al.  Letter: Haemophilia carriers. , 1974, Lancet.

[48]  E. Wynder,et al.  A study of environmental factors in carcinoma of the cervix. , 1954, American journal of obstetrics and gynecology.

[49]  D. Truzzolillo 23. On the Influence of Circumcision in Preventing Syphilis , 2022 .